Echocardiographic Assessment of Right Ventricular Function in Clinically Well Pediatric Heart Transplantation

Brian R White1, Hannah Katcoff2, Jennifer A Faerber2

  • 1Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Insights

Pediatric heart transplant recipients show reduced right ventricular function, particularly longitudinal shortening, compared to healthy children. Fractional area change (FAC) is relatively preserved, offering a potentially more reliable metric in this population.

Area of Science:

  • Cardiology
  • Pediatric Transplant Medicine
  • Echocardiography

Background:

  • Echocardiographic monitoring is crucial after pediatric heart transplantation due to risks of rejection and ventricular dysfunction.
  • Adult studies indicate altered right ventricular function post-transplant, but pediatric data are limited.

Purpose of the Study:

  • To assess right ventricular systolic function in pediatric heart transplant recipients using echocardiography.
  • To establish normative data for right ventricular function metrics in this population.

Main Methods:

  • Retrospective analysis of echocardiograms from 127 pediatric heart transplant recipients, remote from adverse events.
  • Measurement of tricuspid annular plane systolic excursion (TAPSE), fractional area change (FAC), and peak systolic tricuspid annular tissue velocity (S').
  • Comparison with 380 healthy, age-matched control subjects.

Main Results:

  • Pediatric heart transplant recipients had significantly lower TAPSE (Z score -3.38) and S' values compared to controls.
  • FAC was also significantly decreased, but 83% of transplant patients fell within the normal range.
  • Longitudinal measures (TAPSE and S') were more affected than FAC.

Conclusions:

  • Pediatric heart transplant recipients exhibit diminished right ventricular systolic function, with longitudinal parameters being particularly impaired.
  • Fractional area change (FAC) is relatively preserved and may serve as a more robust echocardiographic metric in this cohort.
  • Established nomograms aid in quantifying functional changes in pediatric heart transplant patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
146
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
639